Identification of novel inhibitors of the PAX3-FOXO1 fusion oncogene in rhabdomyosarcoma

被引：0
|
作者：
Kim, Yong Yean [1 ]
Hawley, Robert [2 ]
Gryder, Berkley [1 ]
Pomella, Silvia [3 ]
Kowalczyk, Josh [1 ]
Sinniah, Ranu [1 ]
Song, Young [1 ]
Khan, Javed [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] George Washington Univ, Washington, DC USA
[3] Osped Pediat Bambino Gesu, Rome, Italy
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-4175
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4175
引用
收藏
页数：2
相关论文
共 50 条
  • [41] FANCD2 Is a Potential Therapeutic Target and Biomarker in Alveolar Rhabdomyosarcoma Harboring the PAX3-FOXO1 Fusion Gene
    Singh, Mamata
    Leasure, Justin M.
    Chronowski, Christopher
    Geier, Brian
    Bondra, Kathryn
    Duan, Wenrui
    Hensley, Lauren A.
    Villalona-Calero, Miguel
    Li, Ning
    Vergis, Anthony M.
    Kurmasheva, Raushan T.
    Shen, Changxian
    Woods, Gary
    Sebastian, Nikhil
    Fabian, Denise
    Kaplon, Rita
    Hammond, Sue
    Palanichamy, Kamalakannan
    Chakravarti, Arnab
    Houghton, Peter J.
    CLINICAL CANCER RESEARCH, 2014, 20 (14) : 3884 - 3895
  • [42] Inhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy options
    J M Loupe
    P J Miller
    D R Ruffin
    M W Stark
    A D Hollenbach
    Oncogenesis, 2015, 4 : e145 - e145
  • [43] JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells
    Walters, Z. S.
    Villarejo-Balcells, B.
    Olmos, D.
    Buist, T. W. S.
    Missiaglia, E.
    Allen, R.
    Al-Lazikani, B.
    Garrett, M. D.
    Blagg, J.
    Shipley, J.
    ONCOGENE, 2014, 33 (09) : 1148 - 1157
  • [44] JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells
    Z S Walters
    B Villarejo-Balcells
    D Olmos
    T W S Buist
    E Missiaglia
    R Allen
    B Al-Lazikani
    M D Garrett
    J Blagg
    J Shipley
    Oncogene, 2014, 33 : 1148 - 1157
  • [45] Early detection of the PAX3-FOXO1 fusion gene in circulating tumor-derived DNA in a case of alveolar rhabdomyosarcoma
    Eguchi-Ishimae, Minenori
    Tezuka, Mari
    Kokeguchi, Tomoki
    Nagai, Kozo
    Moritani, Kyoko
    Yonezawa, Sachiko
    Tauchi, Hisamichi
    Tokuda, Kiriko
    Ishida, Yasushi
    Ishii, Eiichi
    Eguchi, Mariko
    GENES CHROMOSOMES & CANCER, 2019, 58 (08): : 521 - 529
  • [46] Transcriptional complexes involving PAX3-FOXO1
    Weatherspoon, Amber
    Cherlin, Tess
    Johanson, Kelly
    FASEB JOURNAL, 2016, 30
  • [47] PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma
    Thalhammer, Verena
    Lopez-Garcia, Laura A.
    Herrero-Martin, David
    Hecker, Regina
    Laubscher, Dominik
    Gierisch, Maria E.
    Wachtel, Marco
    Bode, Peter
    Nanni, Paolo
    Blank, Bernd
    Koscielniak, Ewa
    Schaefer, Beat W.
    CANCER RESEARCH, 2015, 75 (01) : 98 - 110
  • [48] PAX3-FOXO1: Zooming in on an "undruggable" target
    Wachtel, Marco
    Schafer, Beat W.
    SEMINARS IN CANCER BIOLOGY, 2018, 50 : 115 - 123
  • [49] Utilizing CRISPR-Cas13 as a novel functional genomics tool to characterize PAX3-FOXO1 in alveolar rhabdomyosarcoma
    Zhao, Andrea
    Brown, Lauren M.
    Fareh, Mohamed
    Ekert, Paul G.
    CANCER RESEARCH, 2024, 84 (06)
  • [50] PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma
    Pandey, Puspa R.
    Chatterjee, Bishwanath
    Olanich, Mary E.
    Khan, Javed
    Miettinen, Markku M.
    Hewitt, Stephen M.
    Barr, Frederic G.
    JOURNAL OF PATHOLOGY, 2017, 241 (05): : 626 - 637
12345